Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
AstraZeneca
Julphar
Chinese Patent Office
McKinsey
Harvard Business School
Fish and Richardson
Accenture
McKesson

Generated: April 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019127

« Back to Dashboard

NDA 019127 describes EXIDINE, which is a drug marketed by Xttrium and is included in four NDAs. It is available from twenty-five suppliers. Additional details are available on the EXIDINE profile page.

The generic ingredient in EXIDINE is chlorhexidine gluconate. There are fifty-seven drug master file entries for this compound. Sixty-two suppliers are listed for this compound. Additional details are available on the chlorhexidine gluconate profile page.
Summary for 019127
Tradename:EXIDINE
Applicant:Xttrium
Ingredient:chlorhexidine gluconate
Patents:0
Therapeutic Class:Dental and Oral Agents
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 019127
Suppliers and Packaging for NDA: 019127
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
EXIDINE chlorhexidine gluconate AEROSOL, METERED;TOPICAL 019127 NDA Becton, Dickinson and Company 17271-505 N 17271-505-02
EXIDINE chlorhexidine gluconate AEROSOL, METERED;TOPICAL 019127 NDA Becton, Dickinson and Company 17271-505 N 17271-505-01

Profile for product number 001

Active Rx/OTC/Discontinued:OTCDosage:AEROSOL, METERED;TOPICALStrength4%
Approval Date:Dec 24, 1984TE:RLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Boehringer Ingelheim
Farmers Insurance
Argus Health
Colorcon
Chubb
Chinese Patent Office
AstraZeneca
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.